Loading
Welcome at World Crypto Global. This portal is packed with useful content and resources to built out your own crypto skills. WorldCrypto is a site member of Gabriel Vega Network.
September 4, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech stocks and digital health stocks, reports on trading for Butterfly Network Inc. (NYSE: BFLY), a digital health company transforming care with portable semiconductor-based ultrasound technology and intuitive software.
September 4, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering health and wellness issues a snapshot looking at news and developments for the telemedicine and weight loss market, featuring new player in the market, Integrated Ventures, Inc. (OTCQB: INTV), a portfolio holdings company, focused on e-commerce technology, digital assets and consumer-focused investments.
The BIO Association, a Swiss nonprofit, has unveiled plans to launch BIO tokens ahead of its decentralized biotech network, BIO Protocol, according to a Sept. 30 statement shared with CryptoSlate. The association seeks to bridge the gap between biotechnology and crypto through its decentralized biotech network. This platform will serve as a launchpad for on-chain […]
The post Swiss nonprofit BIO Association to launch BIO tokens for decentralized biotech network appeared first on CryptoSlate.
Christian Angermayer claimed the United Kingdoms latest tax proposal for non-doms would be a huge mistake and be a bigger act of national self-harm than Brexit.
Project Guacamaya leverages AI and satellite technology to protect the Amazon rainforest, monitor deforestation, and preserve biodiversity. (Read More)
September 26, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Pasithea Therapeutics Corp. (NASDAQ: KTTA), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications.
Despite the regulatory hurdles, the projects WLD token surged 35% this week, from $1.60 on Sept. 19 to $2.16 on Sept. 26.
September 24, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health.
September 24, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech technology stocks reports on trading and news for Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases.
September 20, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform covering cannabis stocks releases an industry snapshot looking at the battle against dangerous drugs, including fentanyl, featuring Greenlane Holdings, Inc. (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products.
SAN DIEGO - September 19, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that, on September 9, 2024, the Medanta Institutional Ethics Committee (MIEC) granted full ethics approval for Aethlon's safety, feasibility and dose-finding clinical trial of the Hemopurifier in cancer patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).
September 19, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, featuring Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections.
SAN DIEGO - September 17, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that management will present at the following virtual investor conferences in September
September 17, 2024 (Investorideas.com Newswire) Stocks mentioned-Aethlon Medical, Inc. (Nasdaq: AEMD), Immuneering (Nasdaq: IMRX), Merck (NYSE: MRK), AstraZeneca (Nasdaq: AZN) Roche (OTCQX: RHHBY).
SAN DIEGO - September 16, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that the Cancer Clinical Trial Unit at Royal Adelaide Hospital was activated on September 10, 2024 to begin screening and enrolling patients in its safety, feasibility and dose-finding clinical trial of the Hemopurifier in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).
SAN DIEGO - September 13, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that Jim Frakes, interim CEO and CFO and Steve LaRosa, Chief Medical Officer, will present live at the Life Sciences Investor Forum, hosted by VirtualInvestorConferences.com, on September 19th 2024.
August 9, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech stocks reports on trading for FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development.
August 6, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, including biotech stocks reports on trading for VBI Vaccines Inc. (Nasdaq: VBIV), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease.
Interactions with Ethereum DApps are soaring, but ETH price has failed to react.
August 28, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform covering health and wellness and biotech stocks issues a snapshot looking at news and developments for the global GLP-1 receptor agonist market, featuring new player in the market, Integrated Ventures, Inc. (OTCQB: INTV).
World Crypto Global opens the door to digital freedom for everyone.
Manage your free WCG Coins securely—where simplicity meets global accessibility.
FREE CRYPTO COINS
AVAILABLE FOR RESERVATION
ALREADY ALLOCATED
No fees. No catch. Your crypto journey starts here.
World Crypto Global
